Gangloff Scott A. 4
4 · Akero Therapeutics, Inc. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
Gangloff Scott A.
Chief Technology Officer
Transactions
- Award
Common Stock
2024-12-16+24,300→ 24,300 total - Award
Stock Option (Right to Buy)
2024-12-16+73,700→ 73,700 totalExercise: $29.23Exp: 2034-12-15→ Common Stock (73,700 underlying)
Footnotes (2)
- [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in eight (8) equal semi-annual installments, commencing from December 16, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- [F2]This option shall vest and become exercisable in forty-eight (48) equal monthly installments, commencing from December 16, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.